BackgroundKetamine elicits an acute antidepressant effect in patients with major depressive disorder (MDD). Here, we used diffusion imaging to explore whether regional differences in white matter microstructure prior to treatment may predict clinical response 24h following ketamine infusion in 10 MDD patients.MethodsFSL's Tract-Based Spatial Statistics (TBSS) established voxel-level differences in fractional anisotropy (FA) between responders (patients showing >50% improvement in symptoms 24h post-infusion) and non-responders in major white matter pathways. Follow-up regions-of-interest (ROI) analyses examined differences in FA and radial (RD), axial (AD) and mean diffusivity (MD) between responders and non-responders and 15 age- and sex...
Whether plasticity of white matter (WM) microstructure relates to therapeutic response in major depr...
Ketamine is a promising treatment option for patients with Major Depressive Disorder (MDD) and has b...
Background Ketamine is receiving increasing attention as a rapid-onset antidepressant in patients su...
Ketamine was recently approved for treatment resistant depression. However, despite its therapeutic ...
Increasing preclinical and clinical evidence underscores the strong and rapid antidepressant propert...
Using resting state fMRI (rsfMRI), the „dorsal nexus“ (DN) was recently identified as a dorsomedial ...
Major depressive disorder (MDD) is characterized by heterogeneous cognitive, affective and somatic s...
Converging evidence suggests that a single sub-anesthetic dose of ketamine can produce strong and ra...
Background: An urgent need exists for faster-acting pharmacological treatments in major depressive d...
Background Identifying the neural correlates of ketamine treatment may facilitate and expedite the d...
Over the past decade, various N-methyl-D-aspartate modulators have failed in clinical trials, unders...
Increasing preclinical and clinical evidence underscores the strong and rapid antidepressant propert...
Subanesthetic ketamine is found to induce fast-acting and pronounced antidepressant effects, even in...
Background / Purpose: Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidep...
Background: Ketamine is receiving increasing attention as a rapid-onset antidepressant in patients s...
Whether plasticity of white matter (WM) microstructure relates to therapeutic response in major depr...
Ketamine is a promising treatment option for patients with Major Depressive Disorder (MDD) and has b...
Background Ketamine is receiving increasing attention as a rapid-onset antidepressant in patients su...
Ketamine was recently approved for treatment resistant depression. However, despite its therapeutic ...
Increasing preclinical and clinical evidence underscores the strong and rapid antidepressant propert...
Using resting state fMRI (rsfMRI), the „dorsal nexus“ (DN) was recently identified as a dorsomedial ...
Major depressive disorder (MDD) is characterized by heterogeneous cognitive, affective and somatic s...
Converging evidence suggests that a single sub-anesthetic dose of ketamine can produce strong and ra...
Background: An urgent need exists for faster-acting pharmacological treatments in major depressive d...
Background Identifying the neural correlates of ketamine treatment may facilitate and expedite the d...
Over the past decade, various N-methyl-D-aspartate modulators have failed in clinical trials, unders...
Increasing preclinical and clinical evidence underscores the strong and rapid antidepressant propert...
Subanesthetic ketamine is found to induce fast-acting and pronounced antidepressant effects, even in...
Background / Purpose: Ketamine is a potent glutamatergic NMDA receptor antagonist with rapid antidep...
Background: Ketamine is receiving increasing attention as a rapid-onset antidepressant in patients s...
Whether plasticity of white matter (WM) microstructure relates to therapeutic response in major depr...
Ketamine is a promising treatment option for patients with Major Depressive Disorder (MDD) and has b...
Background Ketamine is receiving increasing attention as a rapid-onset antidepressant in patients su...